LENISNA 200

LENISNA 200 is a biostimulator with:
- The world's only hybrid formula based on Poly-D,L-Lactide and hyaluronic acid, with a particle size between 50 and 60 micrometres.
- Completely natural effect.
- Progressive release over time.

- VAIM CO., LTD
- NAME: LENISNA 200
- COMPOSITION: PDLLA polylactic acid: 170 mg. Non-cross-linked hyaluronic acid: 30 mg.
- PRESENTATION: 1 x 200mg.
- INDICATIONS: LENISNA 200 is indicated for treating skin with visible signs of ageing, sunken areas of the face, furrows, wrinkles and folds, firming of relaxed skin on the face, arms, abdomen, thighs and buttocks.
- INJECTION DEPTH: Intradermal or subcutaneous. LENISNA 200 should be administered using a 22-25G gauge cannula or 25-26G gauge needles.
- DURATION: The effects of the therapy are visible immediately after administration, thanks to the filling action of the hyaluronic acid. After about two weeks, the production of collagen stimulated by PDLLA polylactic acid microparticles begins. Treatment results last more than two years after the last session. The recommended number of treatments is 2 or 3, depending on the skin imperfection, with intervals of 6-8 weeks. A maintenance session is recommended after two years.
- USE: Strict medical use.

- Vial: 1 x 200mg.

Face, inner thighs, abdomen, buttocks, arms.

PDLLA polylactic acid: 170 mg. Non-cross-linked hyaluronic acid: 30 mg.

- LENISNA 200 should only be administered by qualified personnel.
- The application must take place under aseptic conditions, observing proper hygiene and preparation.
- Before use, the product should be diluted according to the manufacturer's instructions (e.g. sterile water or saline + 1-2 ml lidocaine) to improve the comfort of the procedure.
- A suitable cannula or needle (e.g. 22-25 G cannula or 25-26 G needle) should be used for injection into the subcutaneous tissue.
- The product is intended for use in selected suitable areas requiring toning or volumising (e.g. face, body).
- After preparation of the product, if not used immediately, the prescribed conditions (e.g. refrigerated storage times etc.) must be followed as per official protocols.

LENISNA 200 is contraindicated in the following cases:
- Pregnancy.
- Breastfeeding.
- Active infections.
- Collagen diseases.
- Active and uncontrolled autoimmune diseases.
- Allergy to product ingredients.
- Inflammation of the skin in the area intended for treatment.

INDICATIONS
LENISNA 200 is ideal for filling skin cavities, restoring and increasing soft tissue volume. It is recommended for reconstructive purposes in the treatment of morphological asymmetries.